Go to Page # Page of 22

New Biological Therapies for Asthma: Do the Benefits Justify the Cost?

 Aruni S. Arachchige Don PhD, Ed Saltzman, John Oppenheimer FACAAI MD
  10th-Jan-2017
Description: The information in this report has been obtained from what are believed to be reliable sources and has been verified whenever possible. Nevertheless, we cannot guarantee the information contained herein as to accuracy or completeness. All expressions of opinion are the responsibility of Defined Health, and though current as of the date of this report, are subject to change. Without the prior written consent of Defined Health, this report may not be relied on in whole or in part for any other purpose or by any other person or entity, provided that this report may be disclosed where disclosure is required by law.
Views: 1078
Domain: Medical
Category: Therapy
Contributing Organization: Defined Health
 ‐ More of their Presentations
SEMICONDUCTOR ANALYTICS
Contents:
New Biological Therapies for Asthma:
Do the Benefits Justify the Cost?
Aruni S. Arachchige Don, PhD
Consultant, Defined Health
Ed Saltzman
President, Defined Health
John Oppenheimer, FACAAI, MD
Director of Clinical Research
Pulmonary and Allergy Associates, and
Clinical Professor of Medicine, Rutgers University
May 17, 2016

The information in this report has been obtained from what are believed ... See more

Recent Presentations

Senhwa Biosciences, Inc

The information contained in this confidential document (“Presentation”) has been prepared by Senhwa Biosciences (the "Company"). It has not been fully verified and is subject to m

...
19 May, 2018
...
18 May, 2018

Real World Evidence: Sanofi's Strategy

The availability of real-world data (RWD) and the use of the appropriate analytical methods create a big opportunity to accelerate/increase patient access to innovative medicines.

...
17 May, 2018